About CPHI Japan 2025
ICE Pharma attended CPHI Japan 2025 which took place in Tokyo from April 9th to 11th.
CPHI Japan is a leading trade exhibition for pharmaceutical industry held every year at Tokyo Big Sight. featuring a wide range of products and equipment. The event brings pharma professionals together to network, learn and conduct vital face-to-face business.
A huge thank you to everyone who visited our booth, engaged with our team, and explored how ICE Pharma’s bile acid-based solutions and contract manufacturing services can support your pharmaceutical projects.
Your insights, discussions, and collaborations make events like this so valuable. If we didn’t get a chance to connect, feel free to reach out—we’d love to continue the conversation!
Come see usWho We Are
ICE Pharma is a multinational company providing products and services to the pharmaceutical and healthcare markets
Founded more than 70 years ago, the Company has a network of manufacturing facilities and subsidiaries in North and South America, Europe, Asia and Oceania. We commercialise our products and services in all the major global markets and serve customers in over 50 countries.
We are a key supplier to the pharmaceutical industry providing a range of active pharmaceutical ingredients (APIs) including Ursodeoxycholic acid (UDCA) and Inosine Pranobex. We also supply excipients, cell culture media for diagnostics, GMP intermediates and research chemicals. Our services business provides contract manufacturing for solid and liquid finished dosage forms.
We manufacture and commercialise branded products in the pharmaceutical, nutraceutical and cosmetics markets.